Neurochem Res (2008) 33(9):184551
A licensed clinician makes that determination based on your individual health profile
NO-releasing agents, such as JS-K ( O 2 -(2,4-dinitrophenyl)-1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate) 123 and PABA/NO ( O 2 -[2,4-dinitro-5-( N -methyl- N -4 carboxyphenylamino)phenyl] 1- N , N -dimethylamino)diazen-1-ium-1,2-diolate) 124 , are able to induce differentiation and cell death in a variety of cancer cells through GSH consumption, DNA synthesis inhibition and inhibition of enzymes involved in the defense against cell damage
For someone with metabolic syndrome who jumps on a GLP-1 and drinks heavily every weekend, thats a different risk profile than someone with well-controlled diabetes, normal lipids, and no alcohol use, Perez said